Eunice Kim

Eunice Kim is a seasoned professional with a strong academic background and extensive experience in healthcare strategy, market access, and marketing.

She holds a Master of Business Administration (MBA) degree with a focus on Business, Management, Marketing, and Related Support Services from The University of Hong Kong, complemented by a Bachelor of Arts (B.A.) in English from Hanyang University.

Eunice Kim has held several significant positions in renowned organizations. She is currently the VP of Global Product & Launch Strategy for Rare Genetics & Hematology at Takeda, showcasing her leadership and strategic acumen.

Prior to her current role, Eunice served as a Visiting Professor of Health Policy and Outcomes Research at Sungkyunkwan University, highlighting her academic contributions and expertise in the healthcare sector.

Her tenure at Takeda also includes leadership roles as the Head of Global Market Access and Hematology, demonstrating her proficiency in market access strategies within the pharmaceutical industry.

Eunice Kim's impressive career extends to global corporations like Novartis Oncology and Eli Lilly and Company, where she held executive positions in market access, value, and evidence roles, underscoring her diverse skill set and industry knowledge.

Her rich professional background further includes experience in brand marketing, communications, and government affairs, with notable roles at companies like Edelman, Ogilvy, and Mayer/McCann Erickson.

With a track record of driving successful product launches, market access initiatives, and brand strategies across various geographies, Eunice Kim is a versatile professional known for her strategic vision and results-driven approach.